Fritextsökning
Innehållstyper
-
ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics
Live imaging with uniform super-resolution in all spatial dimensions.
-
AstraZeneca moves to brewery quarters in central Copenhagen
AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.
-
Efter stökig process – nu godkänns Leqembi i Australien
Det svenskutvecklade alzheimerläkemedlet Leqembi har till slut godkänts i Australien, efter flera komplicerade turer.
-
TCO easy comparison of electric and pneumatic solutions
Find the right technology for your application and compare CO₂ emission and TCO The shown results are not based on a sizing calculation, parameters like service...
-
“What is important is to create an overview and understanding from different perspectives”
Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diag...
-
"Unclear proposal from the EU Commission on how to solve the MDR challenges"
Even before the EU regulation on medical devices (MDR) came into force, medical technology companies and doctors were concerned that it would endanger the avail...
-
He got inside the head of Sweden’s vaccine hunter
The hunt for the COVID-19 vaccine is the theme of the new book Vaccinjägaren (The Vaccine Hunter). It tells the story of Richard Bergström’s mission as Sweden’s...
-
Efficient use of blood plasma
Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...
-
Product demo with features, software and best-practices
Get interesting insights about ZEISS O-INSPECT duo in our demo recording.
-
Storbritannien öppnar för högre läkemedelspriser – Astra Zeneca sänker i USA
Vita husets hårda linje mot höga läkemedelskostnader får konsekvenser på båda sidor Atlanten. Storbritannien öppnar för dyrare läkemedel i sjukvården för att un...
-
Now it’s settled: The International Vaccine Institute will be located in Stockholm
The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreemen...
-
Neogap värvar tungt namn inom cellterapi
Bioteknikbolaget Neogap Therapeutics fyller på styrelsen med expertis inom cellterapi i form av professor Jonas Mattsson.
-
Hamlet Biopharma rapporterar positiva resultat i fas II-studie
Forskningsbolaget Hamlet Biopharma har slutfört den kliniska fas II-studien med bolagets läkemedelskandidat Alpha1H hos patienter med cancer i urinblåsan.
-
FDA:s rådgivande vaccinmöte inställt – utan förklaring
Ett årligt möte mellan FDA och deras rådgivande vaccinkommitté ställs in.
-
Raised millions to develop a treatment for ´butterfly children´
Fragile as a butterfly’s wing – that’s how people living with Epidermolysis Bullosa are usually described. The Lund-based company Xinnate recently raised SEK 100 million in a new...
-
The Swedish Academy of Sciences: “We have too many researchers”
Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.
-
Novo Nordisk planerar att kapa kostnader när konkurrensen hårdnar
Novo Nordisk slopar två fetmaläkemedel som en del av en omfattande översyn av forskningsportföljen. Samtidigt meddelar att avgående vd:n Lars Fruergaard Jørgens...
-
The Swedish Research Council gets go-ahead for more long-term funding
Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...
-
Mångmiljardaffär i jakten på nästa blockbuster inom cancer
Bristol Myers Squibb betalar upp till 11,1 miljarder dollar, motsvarande 106 miljarder kronor, för att köpa in sig i en av de hetaste läkemedelskandidaterna inom immunonkologi.
-
Advanced Microfluidics Flow Analysis Made Easy
Case study with ZEISS Airyscan.
-
New diagnostic rules raise concerns
In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagno...
-
Investments worth 40 billion in the Öresund region – “A huge investment wave”
A new report reveals that medical companies in the Oresund region are investing like never before.
-
KI’s new super machine measures brain activity in real-time – “A very expensive hairdo”
Using brand-new, super-advanced equipment, researchers at Karolinska Institutet can now measure brain activity in real-time, with higher resolution than previou...
-
Pfizer’s record year – topped the $100 billion mark
In 2022 Pfizer, as the first pharmaceutical company in history, reached an annual revenue of more than 100 billion dollars, thereby surpassing Johnson & Johnson...
BREAKING